Cargando…
Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer’s disease
Pathologic, biochemical and genetic evidence indicates that accumulation and aggregation of amyloid β-proteins (Aβ) is a critical factor in the pathogenesis of Alzheimer’s disease (AD). Several therapeutic interventions attempting to lower Aβ have failed to ameliorate cognitive decline in patients w...
Autores principales: | Li, Shaomin, Jin, Ming, Liu, Lei, Dang, Yifan, Ostaszewski, Beth L., Selkoe, Dennis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225562/ https://www.ncbi.nlm.nih.gov/pubmed/30409172 http://dx.doi.org/10.1186/s40478-018-0626-x |
Ejemplares similares
-
How do Soluble Oligomers of Amyloid β-protein Impair Hippocampal Synaptic Plasticity?
por: Li, Shaomin, et al.
Publicado: (2010) -
Soluble Aβ Oligomers Impair Dipolar Heterodendritic Plasticity by Activation of mGluR in the Hippocampal CA1 Region
por: Zhao, Jianhua, et al.
Publicado: (2018) -
Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluid
por: Yang, Ting, et al.
Publicado: (2019) -
Decoding the role of gut microbiota in Alzheimer’s pathogenesis and envisioning future therapeutic avenues
por: Liang, Junyi, et al.
Publicado: (2023) -
Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity
por: Welzel, Alfred T., et al.
Publicado: (2014)